- NSE
- PPLPHARMA
- BSE
- 543635
- ISIN
- INE0DK501011
PIRAMAL PHARMA
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹246.37
+₹7.05 (+2.95%)
NSE close ·
PIRAMAL PHARMA closed at ₹246.37 on 9 Nov 2026, up 2.95% on the day, and is up 23.71% over the past year.
Price history
Between 10 Nov 2025 and 9 Nov 2026, the closing price ranged from ₹133.27 to ₹246.37.
Price returns, excl. dividends. 3Y and Max are annualised. 5Y appears once the stock has that much history.
Fundamentals
- Market cap
- ₹32,800 Cr
- Industry P/E
- 35.5
- EPS (TTM)
- −₹1.58
- P/B
- 4.03
- Book value
- ₹61.16
- ROE
- −2.6%
- ROCE
- 2.2%
- Debt/equity
- 0.70
- Operating margin
- 1.0%
- Net margin
- −2.1%
- Dividend yield
- 0.00%
Market cap, P/B and yield at the 9 Nov 2026 close. TTM: four quarters to 30 Sep 2026 (consolidated). Balance sheet 30 Sep 2026. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Growth | 1Y | 3Y CAGR |
|---|---|---|
| Revenue | +9.65% | +8.92% |
| Net profit | — | — |
Trailing twelve months against the same period 1 and 3 years earlier (3Y as a yearly rate); consolidated.
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Sep 2026 | ₹2,653 Cr | ₹5.03 Cr | — | ₹0.04 |
| Jun 2026 | ₹2,359 Cr | −₹69.39 Cr | — | −₹0.52 |
| Mar 2026 | ₹2,798 Cr | −₹8.82 Cr | −105.75% | −₹0.07 |
| Dec 2025 | ₹2,183 Cr | −₹136 Cr | −3,800.82% | −₹1.03 |
| Sep 2025 | ₹2,109 Cr | −₹99.22 Cr | −539.22% | −₹0.75 |
| Jun 2025 | ₹1,992 Cr | −₹81.70 Cr | — | −₹0.62 |
| Mar 2025 | ₹2,796 Cr | ₹154 Cr | +51.57% | ₹1.16 |
| Dec 2024 | ₹2,216 Cr | ₹3.68 Cr | −63.60% | ₹0.03 |
Armor risk check
PIRAMAL PHARMA moves about 3× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is PIRAMAL PHARMA's share price today?
PIRAMAL PHARMA (NSE: PPLPHARMA) closed at ₹246.37 on 9 Nov 2026, up 2.95% from the previous close of ₹239.32. It traded between ₹242.50 and ₹250.40 that day.
What are PIRAMAL PHARMA's 52-week high and low?
Over the last 52 weeks PIRAMAL PHARMA traded between ₹132.30 and ₹250.40, adjusted for splits and bonuses.
What are PIRAMAL PHARMA's NSE symbol, BSE code and ISIN?
PIRAMAL PHARMA has NSE symbol PPLPHARMA, BSE code 543635, ISIN INE0DK501011.
How has PIRAMAL PHARMA performed over 1, 3 and 5 years?
PIRAMAL PHARMA's share price return: 1Y +23.71%, 3Y +27.96% a year. Dividends are not included.
Does PIRAMAL PHARMA pay a dividend?
Yes. PIRAMAL PHARMA's latest dividend went ex on 16 Jul 2025: Final · ₹0.14 per share.
What is PIRAMAL PHARMA's market cap?
PIRAMAL PHARMA's market cap is ₹32,800 Cr at the close on 9 Nov 2026.
Which sector is PIRAMAL PHARMA in?
PIRAMAL PHARMA is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how PIRAMAL PHARMA fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app